Brazil Simplifies Class I Approvals To Focus On Higher-Risk Products
Executive Summary
Brazil has passed legislation enabling class I (lowest risk) devices and diagnostics to gain market approval through a notification pathway rather than under the current review-based registration system. The move is essentially intended to help regulatory agency Anvisa refocus its efforts toward the higher-risk arena.
You may also be interested in...
Brazil Unifies Registration Coding For Imported And Home-Produced IVDs
In vitro diagnostic (IVD) product registrations in Brazil are now subject to the same procedures and codes, irrespective of whether they are imported or manufactured in the country.
Italian Medtechs Get Legal Boost In ‘Payback’ Tax Fight
The dispute over an “unfair” payback tax looks set to provide both the momentum and ammunition for a full-scale review of how healthcare is funded, seen through the lens of Italian medtech manufacturers and suppliers.
Italy Boosts Per Capita Spend On Medtech, But Key Questions Hang Over Needs
The outlook for sustained COVID-19 recovery in Italy has cheered the medtech industry, but the private sector spend has contracted, and Italy’s imaging equipment is aging rapidly.